FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

21 results

cyclophosphamide
(Cyclophosphamide for Injection)
Slate Run Pharmaceuticals, LLC
Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.
cyclophosphamide
(cyclophosphamide)
Dr. Reddy's Laboratories Inc.
Usage: Cyclophosphamide is indicated for treating malignant diseases in adults and pediatric patients, including various lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is often used in combination with other antineoplastic agents.
cytarabine
(Cytarabine)
Meitheal Pharmaceuticals Inc.
Usage: Cytarabine Injection, in combination with other anti-cancer drugs, is indicated for remission induction in acute non-lymphocytic leukemia, acute lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. It is also used intrathecally for prophylaxis and treatment of meningeal leukemia.
dasatinib
(Dasatinib)
Dr. Reddy's Laboratories Inc.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and those with advanced Ph+ CML or Ph+ acute lymphoblastic leukemia (ALL) who are resistant or intolerant to prior therapy. They are also approved for pediatric patients with Ph+ CML and newly diagnosed Ph+ ALL.
dasatinib
(dasatinib)
Biocon Pharma Inc.
Usage: Dasatinib is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, Ph+ CML with resistance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). It is also indicated for pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL.
dasatinib
(Dasatinib)
Apotex Corp.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Ph+ chronic myeloid leukemia (CML) in chronic phase, resistant or intolerant Ph+ CML, and Ph+ acute lymphoblastic leukemia (ALL). It is also for pediatric patients (1 year and older) with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
dasatinib
(dasatinib)
Prasco Laboratories
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML), Ph+ CML with resistance/intolerance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). They are also indicated for pediatric patients (≥1 year) with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
dasatinib
(dasatinib)
Zydus Pharmaceuticals USA Inc.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, and for chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy, as well as for Ph+ acute lymphoblastic leukemia (ALL) under similar conditions.
frindovyx
(Cyclophosphamide)
Avyxa Pharma, LLC
Usage: FRINDOVYX is indicated for treating malignant lymphomas, multiple myeloma, various leukemias, advanced mycosis fungoides, disseminated neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma in adult and pediatric patients. It is often used in combination with other antineoplastic agents.
imatinib mesylate
(imatinib mesylate)
Archis Pharma LLC
Usage: This drug is indicated for the treatment of newly diagnosed Philadelphia positive chronic myeloid leukemia (Ph+ CML), Ph+ CML in various stages post-interferon therapy, relapsed/refractory Ph+ acute lymphoblastic leukemia (ALL), myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and Kit+ gastrointestinal stromal tumors.

Medications for Precursor Cell Lymphoblastic Leukemialymphoma

cyclophosphamide

cyclophosphamide

cytarabine

dasatinib

dasatinib

dasatinib

dasatinib

dasatinib

frindovyx

imatinib mesylate